You are here: Industry Insights > therapy

News List

FDA approves magnetic brain-zapping helmet to treat OCD sufferers who don't respond to therapy or drugs dailymail
September 04, 2018
A brain 'zapping' device was approved to treat obsessive compulsive disorder by the US Food and Drug Administration (FDA).
Studies find shorter tuberculosis therapy more effective and safe pharmaceutical-technology
August 07, 2018
Two clinical studies carried out by Research-Institute of the McGill University Health Centre (RI-MUHC) in Canada have shown that a shorter therapy for tuberculosis (TB) is more effective and safe in both children and adults when compared to existing stan
Syncona powers gene therapy startup Freeline to £88M B round fiercebiotech
June 25, 2018
Syncona has dialed up its bet on gene therapy startup Freeline Therapeutics. The life science investor committed £85 million ($112 million) to Freeline’s £88 million series B round, thereby maintaining a big stake in a biotech that is working to redefine
Sarepta leaps 50% on early data for Duchenne gene therapy fiercebiotech
June 25, 2018
Sarepta's shares soared Tuesday morning as it presented preliminary phase 1/2 data for potentially curative gene therapy for boys with Duchenne muscular dystrophy (DMD).
Seattle Genetics gain breakthrough therapy designation pharmafile
March 27, 2018
Seattle Genetics and Astellas have confirmed that the drug candidate they are co-developing, enfortumab, has been given FDA breakthrough therapy designation.
GlaxoSmithKline: Helping people do more, feel better, live longer biospace
March 22, 2018
There are numerous reasons for people to enter into the life sciences industry. It could be the desire to work with cutting-edge technology and research
Targeted therapy for acute myeloid leukemia biospectrumasia
September 05, 2017
The Leukemia & Lymphoma Society (LLS) has played a role in the advancement of each of these therapies at some point along their development.
Final NICE nod for Sanofi’s Gaucher therapy pharmatimes
June 30, 2017
Sanofi’s Cerdelga can now be funded on the NHS in England and Wales to treat type 1 Gaucher disease
First large-scale study gives hope for ketamine as a depression therapy pharmafile
May 04, 2017
While the development of truly innovative mental health therapies has ground to a halt somewhat, scientific
UniQure’s haemophilia B therapy picks up PRIME status pharmatimes
April 27, 2017
uniQure’s investigational gene therapy for patients with the blood clotting disorder haemophilia B has been awarded...

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page